Clinic "ELPIS"
- Address
- lock Available on a paid plan
Clinic ELPIS - Multiple Sclerosis Research Center
Clinic ELPIS is a specialized medical research center dedicated to advancing treatment options for patients with progressive forms of multiple sclerosis. The center participates in cutting-edge multicenter clinical trials focused on identifying novel therapeutic interventions for challenging neurological conditions.
- Primary Progressive Multiple Sclerosis (PPMS) treatment development
- Secondary Progressive Multiple Sclerosis without relapse intervention studies
- Phase 3 randomized controlled trials evaluating oral disease-modifying therapies
With expertise in long-term efficacy and safety evaluation, Clinic ELPIS contributes to 96-week prospective studies that employ rigorous double-blind, placebo-controlled methodologies. The center's research focuses on dose titration strategies and comprehensive patient monitoring to optimize therapeutic outcomes in progressive MS populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 173 other sites in Greece
Therapeutic Area Benchmark — Greece
Select a therapeutic area to compare against other sites in Greece.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Greece
Market Share
Country: Greece
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinic "ELPIS"
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Masitinib Dose Titration in Primary and Secondary Progressive Multiple Sclerosis: A 96-Week Randomized, Double-Blind, Placebo-Controlled Study | Ab Science | Phase III | Not Recruiting | Feb 2024 | Jul 2026 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Masitinib | 1 | Unknown | 2024-02-02 | 2024-02-02 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.